← Leaderboards
Gail E Besner
Research Inst Nationwide Children'S Hosp
$9,533,784
Attributed
$14,181,980
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,181,980 · 9
By mechanism
R01$10,175,890 · 6
R44$2,284,339 · 1
R42$1,390,356 · 1
R41$331,395 · 1
Top collaborators
- Steven D Goodman10 shared
- Michael T Bailey9 shared
- Jed Kizer Johnson2 shared
- Joe Trebley2 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Peter J Giannone$2,446,584
Others in their field
Top investigators on “Intestines”
- Richard S Blumberg · Children'S Hospital Boston$45,768,173
- Mark Donowitz · Johns Hopkins University$37,125,295
- Israel David Goldman · Yeshiva University$32,031,336
- Samuel A Wells · Duke University$31,864,469
- Margaret Rita Karagas · Dartmouth College$30,262,431
- Abhik Das · Research Triangle Institute$30,240,510
Research focus
IntestinesAffectInjuryProductionBaseIn VivoLeadCause Of DeathMorbidity - Disease RateRattusPreventHeparin-Binding Egf-Like Growth FactorCellsNecrotizing EnterocolitisPremature InfantMortality Vital StatisticsIn VitroDesignNeonateAnti-Inflammatory AgentsExposure ToPublic Health Medicine (Field)Multiple Organ FailureNovel Strategies
Grant awards (37)
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment$656,958
R01 · FY2025 · HD
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment$683,916
R01 · FY2024 · HD
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$1,134,186
R44 · FY2020 · GM
Tunable Native Probiotic Formulations for the Treatment of NEC.$317,946
R01 · FY2020 · GM · contact PI
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$1,150,153
R44 · FY2019 · GM
Tunable Native Probiotic Formulations for the Treatment of NEC.$441,859
R01 · FY2019 · GM · contact PI
Tissue Engineered Intestine$695,892
R42 · FY2018 · DK
Tunable Native Probiotic Formulations for the Treatment of NEC.$522,953
R01 · FY2018 · GM · contact PI
Exosomes and HB-EGF in Stem Cell-Mediated Therapy for Necrotizing Enterocolitis$284,050
R01 · FY2018 · GM · contact PI
Tissue Engineered Intestine$694,464
R42 · FY2017 · DK
Tunable Native Probiotic Formulations for the Treatment of NEC.$422,450
R01 · FY2017 · GM · contact PI
Exosomes and HB-EGF in Stem Cell-Mediated Therapy for Necrotizing Enterocolitis$338,656
R01 · FY2017 · GM · contact PI
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$331,395
R41 · FY2017 · GM · contact PI
Tunable Native Probiotic Formulations for the Treatment of NEC.$65,018
R01 · FY2017 · GM · contact PI
Exosomes and HB-EGF in Stem Cell-Mediated Therapy for Necrotizing Enterocolitis$393,263
R01 · FY2016 · GM · contact PI
Exosomes and HB-EGF in Stem Cell-Mediated Therapy for Necrotizing Enterocolitis$284,050
R01 · FY2015 · GM · contact PI
Exosomes and HB-EGF in Stem Cell-Mediated Therapy for Necrotizing Enterocolitis$54,606
R01 · FY2015 · GM · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$311,320
R01 · FY2014 · GM · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$300,424
R01 · FY2013 · GM · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$311,320
R01 · FY2012 · GM · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$311,320
R01 · FY2011 · GM · contact PI
HB-EGF Therapy for Necrotizing Entercolitis$283,539
R01 · FY2011 · DK · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$305,554
R01 · FY2010 · GM · contact PI
HB-EGF Therapy for Necrotizing Entercolitis$286,403
R01 · FY2010 · DK · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$375,840
R01 · FY2009 · GM · contact PI
HB-EGF Therapy for Necrotizing Entercolitis$289,296
R01 · FY2009 · DK · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$295,200
R01 · FY2008 · GM · contact PI
HB-EGF Therapy for Necrotizing Entercolitis$289,296
R01 · FY2008 · DK · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$67,200
R01 · FY2008 · GM · contact PI
Role of NO and Endothelin in Human NEC$308,175
R01 · FY2007 · DK · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$295,200
R01 · FY2007 · GM · contact PI
HB-EGF Therapy for Necrotizing Entercolitis$295,200
R01 · FY2007 · DK · contact PI
Role of NO and Endothelin in Human NEC$317,378
R01 · FY2006 · DK · contact PI
HB-EGF and Intestinal Ischemia/Reperfusion$266,875
R01 · FY2005 · GM
HB-EGF and Intestinal Ischemia/Reperfusion$266,875
R01 · FY2004 · GM
HB-EGF and Intestinal Ischemia/Reperfusion$266,875
R01 · FY2003 · GM
HB-EGF and Intestinal Ischemia/Reperfusion$266,875
R01 · FY2002 · GM